| Net Cash Provided by (Used in) Operating Activities |
$-552,794 |
USD |
90.6% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
62,393,940 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
495,092 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$-552,794 |
USD |
-9295% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$105,149,000 |
USD |
-0.31% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$105,149,000 |
USD |
-0.31% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$18,687 |
USD |
-61.7% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$72,648,000 |
USD |
-2.82% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
833,333 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$488,679,720 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
$639 |
USD |
-69% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$105,149 |
USD |
-0.31% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$3,928 |
USD |
-92.3% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |